Frontiers Up To Date Pathologic Classification And Molecular

Frontiers Up To Date Pathologic Classification And Molecular Citation: chung t and park yn (2022) up to date pathologic classification and molecular characteristics of intrahepatic cholangiocarcinoma. front. med. 9:857140. doi: 10.3389 fmed.2022.857140. Up to date pathologic classification and molecular characteristics of intrahepatic cholangiocarcinoma taek chung1 and young nyun park2* 1 department of biomedical systems informatics, yonsei university college of medicine, seoul, south korea, 2 department of pathology, graduate school of medical science, brain korea 21 project, yonsei.

Pathological Classification Of Intrahepatic Cholangiocarcinoma Based On Up to date pathologic classification and molecular characteristics of intrahepatic cholangiocarcinoma front med (lausanne) . 2022 mar 31:9:857140. doi: 10.3389 fmed.2022.857140. Doi: 10.3389 fmed.2022.857140 corpus id: 247798468; up to date pathologic classification and molecular characteristics of intrahepatic cholangiocarcinoma @article{chung2022uptodatepc, title={up to date pathologic classification and molecular characteristics of intrahepatic cholangiocarcinoma}, author={taek chung and young nyun park}, journal={frontiers in medicine}, year={2022}, volume={9. Frontiers in medicine (mar 2022) up to date pathologic classification and molecular characteristics of intrahepatic cholangiocarcinoma taek chung,. Data from recent large scale exome analyses have revealed the heterogeneity in the molecular profiles of icca, showing that small duct type icca exhibit frequent bap1, idh1 2 hotspot mutations and fgfr2 fusion, in contrast to frequent mutations in kras, tp53, and smad4 observed in large duct type icca. multi omics analyses have proposed several.